Ventas (VTR)
(Delayed Data from NYSE)
$64.45 USD
+1.23 (1.95%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $64.43 -0.02 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$64.45 USD
+1.23 (1.95%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $64.43 -0.02 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Zacks News
Top Research Reports for Disney, Kraft Heinz & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), Kraft Heinz (KHC) and CVS Health (CVS).
Ventas Sells 22 Kindred-Operated SNFs Out of 36 in Phase I
by Zacks Equity Research
Ventas (VTR) will be able to bring down its NOI from skilled nursing facilities to just 1% of its aggregate NOI, following the anticipated sale of the total 36 Kindred operated facilities.
Ventas' (VTR) Life Science Asset Investments to Stoke Growth
by Zacks Equity Research
Ventas (VTR) is making investment for future prospects through selective development and redevelopment. This would include new ground-up medical office and life science developments.
Top Stock Reports for United Technologies, NVIDIA & Raytheon
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including United Technologies (UTX), NVIDIA (NVDA), and Raytheon (RTN).
Ventas (VTR) Beats Q2 FFO Estimates, Reiterates 2017 View
by Zacks Equity Research
Ventas' (VTR) solid Q2 results were supported by growth in revenues. The company also reiterated its 2017 normalized FFO per share outlook.
Ventas (VTR) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Ventas (VTR) came up with a better-than expected performance in Q2. Results reflect improved property performance and accretive investments.
REIT Stocks' Q2 Earnings Queued for Jul 28: HCN, VTR & IRM
by Zacks Equity Research
The sentiment in Q2 has been mixed so far, with results from some of the top notch REIT stocks either matching estimates or beating, and a few others falling shy of expectations.
PS Business Parks (PSB) Q2 FFO Tops Estimates, Revenues Miss
by Zacks Equity Research
Higher net operating income and reduced interest expenses drove PS Business Parks' (PSB) Q2 results.
Liberty (LPT) Q2 FFO and Revenues Beat, Fall Y/Y, Stock Down
by Zacks Equity Research
Liberty Property's Q2 results reflect rent escalation on renewal and replacement leases signed during the quarter in the industrial portfolio. However, occupancy fell from the prior quarter.
Ventas (VTR) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Ventas is likely to benefit from diversified portfolio and strategic investments. But, supply increase can dampen performance in Q2. Let's see if the stock is poised for a beat.
Ventas (VTR) Reiterates Sale of 36 Kindred Operated SNFs
by Zacks Equity Research
Ventas Inc. (VTR) has reaffirmed the expected sale of 36 skilled nursing facilities (SNFs), for $700 million, which are currently being operated by Kindred Healthcare.
Ventas to Gain from Life Science Real Estate Investments
by Zacks Equity Research
University-based life science real estate is a new zone of investment that has caught attention and Ventas Inc. (VTR) has, by now, committed roughly $2 billion to this segment.
Why Is Ventas (VTR) Up 3.8% Since the Last Earnings Report?
by Zacks Equity Research
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ventas' (VTR) FFO and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Ventas, Inc. (VTR) reported first-quarter 2017 normalized funds from operations of $1.03 per share.
Ventas' (VTR) Q1 FFO & Revenues Beat Estimates
by Zacks Equity Research
Ventas came out with first-quarter 2017 normalized funds from operations (FFO) per share of $1.03.
Duke Realty (DRE) Surpasses FFO & Revenue Estimates in Q1
by Zacks Equity Research
Duke Realty Corporation's (DRE) first-quarter 2017 core funds from operations ("FFO") per share of 32 cents surpassed the Zacks Consensus Estimate of 29 cents and came in 4 cents ahead of the year-ago figure.
Public Storage (PSA) Q1 FFO and Revenues Miss Estimates
by Zacks Equity Research
Public Storage's (PSA) first-quarter 2017 FFO per share of $2.34 missed the Zacks Consensus Estimate of $2.43. Quarterly revenues of $645.5 million also fell short of the Zacks Consensus Estimate.
Extra Space (EXR) Q1 FFO Beats Estimates, Revenues Miss
by Zacks Equity Research
Extra Space Storage Inc.'s (EXR) first-quarter 2017 FFO as adjusted per share of $1.03 surpassed the Zacks Consensus Estimate of 98 cents. Results reflect an improvement in same-store NOI.
Highwoods (HIW) Q1 FFO, Revenues Surpass Estimates
by Zacks Equity Research
Highwoods Properties Inc. (HIW) reported first-quarter 2017 funds from operations of 80 cents per share, beating the Zacks Consensus Estimate by 2 cents.
DDR Corp (DDR) FFO Beats Estimates in Q1, Declines Y/Y
by Zacks Equity Research
DDR Corp. (DDR) reported first-quarter 2017 funds from operations per share of 30 cents, which beating the Zacks Consensus Estimate by a penny.
PS Business Parks (PSB) Beats Q1 FFO & Revenue Estimates
by Zacks Equity Research
PS Business Parks, Inc. (PSB) reported first-quarter 2017 funds from operations ("FFO") of $1.52 per share, surpassing the Zacks Consensus Estimate of $1.41.
Ventas (VTR) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Ventas, Inc. (VTR) is expected to report first-quarter 2017 results on Apr 28, before the market opens.
Ventas (VTR) Down 2.1% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ventas Acquires High-Quality Healthcare Campus in Providence
by Zacks Equity Research
Ventas, Inc. (VTR) announced the acquiring of a high-quality life science, research and medical campus in Providence, Rhode Island from affiliates of Blackstone Real Estate Partners VIII L.P.
Ventas (VTR) Secures Finance for Ardent's Acquisition of LHP
by Zacks Equity Research
Ventas, Inc. (VTR) completed the secured debt financing of $700 million for its subsidiary Ardent Health Services' acquisition of LHP Hospital Group, Inc.